Literature DB >> 2199873

Maternal lithium therapy and polyhydramnios.

M S Ang1, J A Thorp, V M Parisi.   

Abstract

Lithium is widely used in the treatment of bipolar affective disorders, and teratogenic effects include cardiovascular abnormalities, notably Ebstein anomaly. The most common side effect in the patient taking lithium is polyuria, a form of nephrogenic diabetes insipidus. We report the case of a manic-depressive gravida on lithium therapy who developed polyhydramnios in her last trimester. Because lithium crosses the placenta, we postulate that, by a similar mechanism, lithium may cause fetal polyuria which results in polyhydramnios.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199873

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Maternal lithium therapy and neonatal morbidity.

Authors:  Bas Zegers; Peter Andriessen
Journal:  Eur J Pediatr       Date:  2003-02-28       Impact factor: 3.183

Review 2.  Treating recurrent affective disorders during and after pregnancy. What can be taken safely?

Authors:  M Schou
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

3.  Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study.

Authors:  Maria Sagué-Vilavella; Eva Solé; Justo Pinzón-Espinosa; Ana Sandra-Hernández; Ester Roda; Eduard Vieta; Alba Roca
Journal:  Arch Womens Ment Health       Date:  2022-05-06       Impact factor: 4.405

Review 4.  Lithium during pregnancy and after delivery: a review.

Authors:  Eline M P Poels; Hilmar H Bijma; Megan Galbally; Veerle Bergink
Journal:  Int J Bipolar Disord       Date:  2018-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.